These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 32455867

  • 1. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.
    Sasahira T, Kurihara-Shimomura M, Nishiguchi Y, Shimomura H, Kirita T.
    Int J Mol Sci; 2020 May 22; 21(10):. PubMed ID: 32455867
    [Abstract] [Full Text] [Related]

  • 2. LEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration.
    Sasahira T, Kurihara M, Nakashima C, Kirita T, Kuniyasu H.
    Br J Cancer; 2016 Jun 28; 115(1):52-8. PubMed ID: 27280633
    [Abstract] [Full Text] [Related]

  • 3. SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis.
    Sasahira T, Kurihara-Shimomura M, Shimomura H, Kirita T.
    Int J Clin Oncol; 2021 Oct 28; 26(10):1831-1839. PubMed ID: 34173120
    [Abstract] [Full Text] [Related]

  • 4. Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma.
    Sasahira T, Ueda N, Yamamoto K, Bhawal UK, Kurihara M, Kirita T, Kuniyasu H.
    Clin Exp Metastasis; 2013 Feb 28; 30(2):165-76. PubMed ID: 22886570
    [Abstract] [Full Text] [Related]

  • 5. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC, Chen PC, Lein MY, Tsao CW, Huang CC, Wang SW, Tang CH, Tung KC.
    Oncotarget; 2016 Mar 01; 7(9):9993-10005. PubMed ID: 26824419
    [Abstract] [Full Text] [Related]

  • 6. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.
    Ghosh S, Koblinski J, Johnson J, Liu Y, Ericsson A, Davis JW, Shi Z, Ravosa MJ, Crawford S, Frazier S, Stack MS.
    Mol Cancer Res; 2010 Feb 01; 8(2):145-58. PubMed ID: 20145038
    [Abstract] [Full Text] [Related]

  • 7. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.
    Oncol Rep; 2011 Dec 01; 26(6):1555-60. PubMed ID: 21833477
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L, Wang Y, Xiao M, Lin Y, Yu L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct 01; 110(4):484-91. PubMed ID: 20868995
    [Abstract] [Full Text] [Related]

  • 9. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X, Liu D, Wang L, Wu R, Zeng X, Dan H, Ji N, Jiang L, Zhou Y, Chen Q.
    J Oral Pathol Med; 2016 Apr 01; 45(4):256-61. PubMed ID: 26449957
    [Abstract] [Full Text] [Related]

  • 10. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
    Magnussen SN, Hadler-Olsen E, Costea DE, Berg E, Jacobsen CC, Mortensen B, Salo T, Martinez-Zubiaurre I, Winberg JO, Uhlin-Hansen L, Svineng G.
    BMC Cancer; 2017 May 19; 17(1):350. PubMed ID: 28526008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.